BAJAJ BROKING

Notification
No new Notification messages
Hexaware Technologies IPO is Open!
Apply for the Hexaware Technologies IPO through UPI in just minutes.
Q3 FY'25 Results of Top Companies!
From Reliance Industries to TCS to HDFC Bank, check out the latest quarterly results with financial highlights, key performance metrics, and more!
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
vivo bio tech ltd. stock

VIVO BIO TECH LTD. Share Price

39.35 0.84 (2.18%)
14 Feb 2025 | 03:29 PM Pharmaceuticals NSE: VIVOBIOT

VIVO BIO TECH LTD. Share Price Update

As of the latest trading session, VIVO BIO TECH LTD. share price is currently at 39.35, which is up by 0.84 from its previous closing. Today, the stock has fluctuated between 36.10 and 39.76. Over the past year, VIVO BIO TECH LTD. has achieved a return of -17.82 %. In the last month alone, the return has been -13.84 %. Read More...

VIVO BIO TECH LTD. Performance

Day Range

Low36.10 High39.76
39.15

52 Week Range

Low 31.20 High 56.90
39.15

VIVO BIO TECH LTD. Share Price

511509

VIVOBIOT

img img img img
No Data Available

Open Price

38.90

Prev. Close

38.51

Volume (Shares)

33569.00

Total traded value

12.74

Upper Circuit

46.98

Lower Circuit

31.32

Note: The current prices & values are delayed, Login to your account for live updates.

VIVO BIO TECH LTD. Fundamentals


(Standalone)

Market Cap (Cr) 58.64
PE Ratio (TTM) 8.92
Book Value / Share 37.89
Beta 0.30
ROE 4.74%
EPS (TTM) 4.39
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.89

VIVO BIO TECH LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 12.21
Operating Expense 10.69
Net Profit 0.89
Net Profit Margin (%) 7.28
Earnings Per Share (EPS) 0.60
EBITDA 5.63
Effective Tax Rate (%) 41.55
Particulars SEP 2024 (Values in Cr)
Revenue 12.04
Operating Expense 10.72
Net Profit 5.31
Net Profit Margin (%) 44.10
Earnings Per Share (EPS) 3.56
EBITDA 10.30
Effective Tax Rate (%) 10.58
Particulars JUN 2024 (Values in Cr)
Revenue 10.13
Operating Expense 9.91
Net Profit 0.18
Net Profit Margin (%) 1.77
Earnings Per Share (EPS) 0.12
EBITDA 4.38
Effective Tax Rate (%) 26.08
Particulars MAR 2024 (Values in Cr)
Revenue 11.55
Operating Expense 10.17
Net Profit 0.70
Net Profit Margin (%) 6.06
Earnings Per Share (EPS) 0.47
EBITDA 5.34
Effective Tax Rate (%) 50.35
Particulars DEC 2023 (Values in Cr)
Revenue 12.71
Operating Expense 10.83
Net Profit 1.32
Net Profit Margin (%) 10.38
Earnings Per Share (EPS) 0.89
EBITDA 6.41
Effective Tax Rate (%) 30.89
Particulars MAR 2024 (Values in Cr)
Revenue 44.88
Operating Expense 40.87
Net Profit 2.52
Net Profit Margin (%) 5.61
Earnings Per Share (EPS) 1.69
EBITDA 21.11
Effective Tax Rate (%) 37.77
Particulars MAR 2023 (Values in Cr)
Revenue 51.62
Operating Expense 47.05
Net Profit 2.63
Net Profit Margin (%) 5.09
Earnings Per Share (EPS) 1.77
EBITDA 21.53
Effective Tax Rate (%) 42.73
Particulars MAR 2022 (Values in Cr)
Revenue 51.39
Operating Expense 47.01
Net Profit 2.20
Net Profit Margin (%) 4.28
Earnings Per Share (EPS) 1.56
EBITDA 15.90
Effective Tax Rate (%) 50.78
Particulars MAR 2021 (Values in Cr)
Revenue 51.78
Operating Expense 43.23
Net Profit 5.68
Net Profit Margin (%) 10.96
Earnings Per Share (EPS) 4.24
EBITDA 17.74
Effective Tax Rate (%) 34.10
Particulars MAR 2020 (Values in Cr)
Revenue 55.35
Operating Expense 51.15
Net Profit 4.44
Net Profit Margin (%) 8.02
Earnings Per Share (EPS) 3.45
EBITDA 12.53
Effective Tax Rate (%) -4.46
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.50
ROE % 4.76
ROCE % 9.88
Total Debt to Total Equity 1.27
EBITDA Margin 46.86
Particulars MAR 2023 (Values in Cr)
Book Value / Share 34.81
ROE % 5.35
ROCE % 10.97
Total Debt to Total Equity 1.31
EBITDA Margin 41.89
Particulars MAR 2022 (Values in Cr)
Book Value / Share 32.56
ROE % 4.91
ROCE % 9.25
Total Debt to Total Equity 1.10
EBITDA Margin 31.50
Particulars MAR 2021 (Values in Cr)
Book Value / Share 30.63
ROE % 15.03
ROCE % 18.65
Total Debt to Total Equity 0.73
EBITDA Margin 34.53
Particulars MAR 2020 (Values in Cr)
Book Value / Share 25.62
ROE % 14.73
ROCE % 13.72
Total Debt to Total Equity 0.76
EBITDA Margin 22.62
Particulars MAR 2024 (Values in Cr)
Book Value / Share 36.50
ROE % 4.74
ROCE % 10.06
Total Debt to Total Equity 1.23
EBITDA Margin 47.46
Particulars MAR 2023 (Values in Cr)
Book Value / Share 34.81
ROE % 5.31
ROCE % 11.16
Total Debt to Total Equity 1.27
EBITDA Margin 42.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 32.57
ROE % 4.91
ROCE % 9.47
Total Debt to Total Equity 1.05
EBITDA Margin 31.48
Particulars MAR 2021 (Values in Cr)
Book Value / Share 30.64
ROE % 15.03
ROCE % 19.31
Total Debt to Total Equity 0.67
EBITDA Margin 34.53
Particulars MAR 2020 (Values in Cr)
Book Value / Share 25.63
ROE % 14.72
ROCE % 14.02
Total Debt to Total Equity 0.73
EBITDA Margin 22.64
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.38
Total Assets 137.13
Total Liabilities 137.13
Total Equity 54.39
Share Outstanding 14903520
Price to Book Ratio 1.17
Return on Assets (%) 1.84
Return on Capital (%) 1.98
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.37
Total Assets 123.03
Total Liabilities 123.03
Total Equity 51.87
Share Outstanding 14903520
Price to Book Ratio 0.55
Return on Assets (%) 2.15
Return on Capital (%) 2.32
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.71
Total Assets 122.48
Total Liabilities 122.48
Total Equity 47.12
Share Outstanding 14263520
Price to Book Ratio 1.22
Return on Assets (%) 1.79
Return on Capital (%) 1.92
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.16
Total Assets 79.52
Total Liabilities 79.52
Total Equity 42.52
Share Outstanding 13419520
Price to Book Ratio 1.56
Return on Assets (%) 7.14
Return on Capital (%) 7.73
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.02
Total Assets 63.68
Total Liabilities 63.68
Total Equity 33.02
Share Outstanding 12887520
Price to Book Ratio 0.76
Return on Assets (%) 6.97
Return on Capital (%) 7.74
Particulars MAR 2024 (Values in Cr)
Net Income 4.06
Cash from Operations 18.58
Cash from Investing -7.95
Cash from Financing -7.55
Net change in Cash 0.01
Free Cash Flow 26.53
Particulars MAR 2023 (Values in Cr)
Net Income 4.62
Cash from Operations 18.17
Cash from Investing -3.99
Cash from Financing -11.17
Net change in Cash -0.33
Free Cash Flow 22.17
Particulars MAR 2022 (Values in Cr)
Net Income 4.47
Cash from Operations 20.09
Cash from Investing -51.11
Cash from Financing 35.01
Net change in Cash 0.54
Free Cash Flow 71.20
Particulars MAR 2021 (Values in Cr)
Net Income 8.61
Cash from Operations 20.64
Cash from Investing -22.82
Cash from Financing 8.78
Net change in Cash 0.13
Free Cash Flow 43.46
Particulars MAR 2020 (Values in Cr)
Net Income 4.25
Cash from Operations 11.51
Cash from Investing -10.23
Cash from Financing 2.09
Net change in Cash 0.46
Free Cash Flow 21.75
Particulars MAR 2023 (Values in Cr)
Net Income 4.60
Cash from Operations 18.06
Cash from Investing -3.99
Cash from Financing -11.20
Net change in Cash -0.47
Free Cash Flow 22.06
Particulars MAR 2022 (Values in Cr)
Net Income 4.47
Cash from Operations 19.88
Cash from Investing -51.10
Cash from Financing 35.04
Net change in Cash 0.36
Free Cash Flow 70.99
Particulars MAR 2021 (Values in Cr)
Net Income 8.62
Cash from Operations 20.56
Cash from Investing -22.82
Cash from Financing 8.83
Net change in Cash 0.10
Free Cash Flow 43.38
Particulars MAR 2020 (Values in Cr)
Net Income 4.25
Cash from Operations 10.62
Cash from Investing -7.07
Cash from Financing -0.17
Net change in Cash 0.46
Free Cash Flow 17.69
Particulars MAR 2019 (Values in Cr)
Net Income 1.82
Cash from Operations 1.42
Cash from Investing -3.53
Cash from Financing 0.70
Net change in Cash -3.61
Free Cash Flow 4.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 48.41 27.82 2.64 370.98 39.20 / 77.70
BLISS GVS PHARMA LTD 132.25 17.33 1.37 1393.52 92.25 / 184.95
CIPLA LTD 1459.05 23.62 4.15 117834.93 1317.60 / 1702.00
FERMENTA BIOTECH LIMITED 298.95 24.77 3.03 879.84 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 48.41 42.10 8.23 370.98 39.20 / 77.70
AMRUTAJAN HEALTH LTD 612.45 35.90 5.94 1770.63 591.10 / 861.40
ASTRAZENECA PHARMA IND LT 7096.35 105.84 26.11 17740.88 4050.15 / 8139.85
BLISS GVS PHARMA LTD 132.25 17.18 1.36 1393.52 92.25 / 184.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 40.00
  • 26 Days 43.10
  • 10 Days 41.50
  • 50 Days 42.60
  • 12 Days 42.00
  • 100 Days 41.30
  • 20 Days 42.90
  • 200 Days 40.00
39.62
PIVOT
First Resistance 41.73
Second Resistance 44.96
Third Resistance 47.07
First Support 36.39
Second Support 34.28
Third Support 31.05
RSI 36.82
MACD -1.16
Commodity Channel Index (CCI) -161.23
ADX 15.02
Williams % R -71.50

Over 1 Month

down

-13.84

Over 3 Months

down

14.07

Over 6 Months

down

6.01

Over 1 Year

down

-17.82

Over 3 Years

down

-1.08

Over 5 Years

down

6.93

VIVO BIO TECH LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

VIVO BIO TECH LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
61.11
Promoter Holdings
38.88
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Cryptologic Systems Private Limited Shareholding of Promoter and Promoter Group 1345000.0 8.34
Elite Class Asset Holdings Ltd Public Shareholding 1300000.0 8.06
Maxcell Phones Communications India Private Limited Shareholding of Promoter and Promoter Group 1200000.0 7.44
Shri Shri Resorts Pvt Ltd Shareholding of Promoter and Promoter Group 1067000.0 6.62
Iragavarapu Constructions Private Limited Shareholding of Promoter and Promoter Group 1000000.0 6.2
Mallemkonda Realities Pvt Ltd Public Shareholding 877615.0 5.44
Every Wear Import And Export Private Limited Public Shareholding 626817.0 3.89
Pki Solutions Private Limited Shareholding of Promoter and Promoter Group 600000.0 3.72
Iron Age India Ltd Shareholding of Promoter and Promoter Group 600000.0 3.72
Rite Equity Sdn Bhd Public Shareholding 561909.0 3.48
Anil Pinapala Public Shareholding 260000.0 1.61
Kompella Madhavi Latha Shareholding of Promoter and Promoter Group 250000.0 1.55
Sridhar Yadav Indur Public Shareholding 200000.0 1.24
Kannan Nadar Public Shareholding 200000.0 1.24
Jyothika Vanamali Public Shareholding 200000.0 1.24
Kompella Viswanath Shareholding of Promoter and Promoter Group 150100.0 0.93
Toomuluru Sitamma Shareholding of Promoter and Promoter Group 59400.0 0.37

VIVO BIO TECH LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About VIVO BIO TECH LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by VIVO BIO TECH LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Vivo Bio Tech Ltd?

Answer Field

The share price of Vivo Bio Tech Ltd for NSE is ₹ 0.00 and for BSE is ₹ 39.15.

What is the Market Cap of Vivo Bio Tech Ltd?

Answer Field

The market cap of Vivo Bio Tech Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 63.10 Cr. as of now.

What is the 52 Week High and Low of Vivo Bio Tech Ltd?

Answer Field

The 52 Week High and Low of Vivo Bio Tech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 56.90 and ₹ 31.20.

How to Buy Vivo Bio Tech Ltd share?

Answer Field

You can trade in Vivo Bio Tech Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Vivo Bio Tech Ltd?

Answer Field

The 1 year returns on the stock has been -17.82%.

What is the Current Share Price of Vivo Bio Tech Ltd?

Answer Field

Vivo Bio Tech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 39.15 as on 14 Feb 2025 | 03:29 PM.

What is the Market Cap of Vivo Bio Tech Ltd Share?

Answer Field

The market cap of Vivo Bio Tech Ltd for NSE ₹ 0.0 & for BSE ₹ 63.10 as on 14 Feb 2025 | 03:29 PM.

What is the P/E Ratio of Vivo Bio Tech Ltd Share?

Answer Field

As on 14 Feb 2025 | 03:29 PM the price-to-earnings (PE) ratio for Vivo Bio Tech Ltd share is 8.92.

What is the PB ratio of Vivo Bio Tech Ltd Share?

Answer Field

As on 14 Feb 2025 | 03:29 PM, the price-to-book (PB) ratio for Vivo Bio Tech Ltd share is 37.89.

How to Buy Vivo Bio Tech Ltd Share?

Answer Field

You can trade in Vivo Bio Tech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vivo Bio Tech Ltd Share on Bajaj Broking App?

Answer Field

To buy Vivo Bio Tech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vivo Bio Tech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

9 Lacs+ Users

icon-with-text

4.1+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5100+ Cr MTF Book

icon-with-text
loader